Thuja Capital is an early-stage venture capital firm that invests in innovative medical product companies within the Benelux region, including therapeutics, medical devices, diagnostics, and digital health solutions. Their strategy focuses on companies developing products that require clinical validation, aim to improve healthcare quality, and enable cost-effective care.
100% of their portfolio is in Biotech & Life Sciences. They made 1 investments in the last 12 months. Their most common stage is series-b (100% of deals).
Portfolio
1
Fund Size
—
Top Stage
Series B
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Portfolio
1 investment
| Company | Round | Amount | Date |
|---|---|---|---|
| SSalvia Bioelectronics | Series B | $60M | May 2025 |
Top Co-Investors
Last updated: 4 May 2026